Diabetes Care Market Demonstrates Long-Term Growth Potential At 8.6% CAGR

The diabetes care sector is poised for considerable expansion as advancements in technology and patient-centered approaches transform treatment options. With increasing adoption of digital solutions and innovative insulin delivery systems, the market is set to evolve significantly in the coming years. Let's explore the current market size, key players, prevailing trends, and segment details shaping this important healthcare field.

Diabetes Care Market Size and Growth Outlook Through 2030
The diabetes care market is projected to reach $43.97 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.6%. This strong momentum can be linked to the rise of digital health tools, a surge in connected diabetes devices, expanding acceptance of homecare methods, advancements in insulin delivery mechanisms, and a growing emphasis on patient self-management. Key trends expected to influence market expansion include increased use of continuous glucose monitoring systems, a shift toward home-based diabetes management, broader adoption of insulin pumps, integration of digital management platforms, and a focus on tailored diabetes therapies.

The diabetes care market size has grown strongly in recent years. It will grow from $29.09 billion in 2025 to $31.63 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increasing diabetes prevalence, hospital-based diabetes management, reliance on finger-stick testing, lifestyle changes, aging population.

Download a free sample of the diabetes care market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24206&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Companies Dominating the Diabetes Care Industry
Several prominent organizations lead the diabetes care market, including F. Hoffmann-La Roche Ltd., Sanofi S.A., Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim Pharmaceuticals Inc., Terumo Corporation, Dexcom Inc., Dr. Reddy's Laboratories Limited, SD Biosensor Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifeScan Inc., Ypsomed AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Bionime Corporation, Arkray Inc., ACON Laboratories Inc., ViCentra B.V., Microtech Medical Ltd., Sinocare Inc., and MicroGene Diagnostic Systems Pvt. Ltd.

Strategic Acquisition to Expand Product Reach
In January 2023, Tandem Diabetes Care Inc., a US-based company specializing in insulin delivery and diabetes technologies, acquired AMF Medical SA for an undisclosed sum. This acquisition aims to accelerate the innovation and commercialization of patch pump technology, broadening Tandem's portfolio and patient outreach. AMF Medical SA, headquartered in Switzerland, focuses on medical technologies designed for diabetes management, particularly insulin delivery solutions.

View the full diabetes care market report:
https://www.thebusinessresearchcompany.com/report/diabetes-care-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Technological Advancements Driving Diabetes Care Innovation
Key players in the diabetes care space are concentrating on cutting-edge technologies such as automated insulin delivery (AID) systems, which merge continuous glucose monitoring (CGM) with insulin pumps to automatically adjust insulin doses based on real-time glucose readings. An AID system enhances glucose control by integrating these technologies for seamless diabetes management.

One notable example emerged in February 2024 when Tandem Diabetes Care Inc. launched the Tandem Mobi, noted as the smallest and most durable automated insulin pump available worldwide. This discreet, tubed insulin pump is fully controllable through a smartphone app, allowing users to manage their diabetes without relying on a traditional handheld controller. The device is waterproof, rechargeable, and works in conjunction with Dexcom's CGM system to automate insulin delivery using Tandem's established Control-IQ technology.

Detailed Segment Insights in the Diabetes Care Market
This report breaks down the diabetes care market into several important segments:

1) By Product Type:
- Glucose Monitoring Devices
- Insulin Pumps

2) By Diabetes Type:
- Type 2 Diabetes
- Type 1 Diabetes
- Other Diabetes Types

3) By End User:
- Hospitals and Clinics
- Homecare Settings
- Ambulatory Care Settings
- Other End Users

Subcategories include:

1) Glucose Monitoring Devices:
- Blood Glucose Monitoring (BGM)
- Continuous Glucose Monitoring (CGM)
- Flash Glucose Monitoring (FGM)

2) Insulin Pumps:
- Patch Pump
- Tethered Pump
- Implanted Insulin Pump

This comprehensive segmentation highlights the varied technologies and care settings contributing to the market's growth and innovation.

New strategic additions in our 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.